Last filing: Jun 23, 2026. Most recent sale before this period: Aug 27, 2025. Most recent purchase on record: Nov 17, 2023.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Aug 27, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | Director | Oct 19, 2021 | Jun 23, 2026 |
| Dianthus Therapeutics, Inc. (DNTH) | Former Chief Operating and Financial Officer | Jan 4, 2019 | Feb 12, 2020 |
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 18, 2026, GeneDx Holdings Corp.: 3,576 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.